Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Try the new Yahoo Finance
Advertisement
U.S. Markets open in 1 hr 40 mins
S&P Futures
5,885.00
-21.00
(-0.36%)
Dow Futures
43,423.00
-95.00
(-0.22%)
Nasdaq Futures
20,352.50
-131.00
(-0.64%)
Russell 2000 Futures
2,282.60
-8.60
(-0.38%)
Crude Oil
70.78
+1.56
(+2.25%)
Gold
2,751.30
+21.30
(+0.78%)
Oncopeptides AB (publ) (ONCO.ST)
Stockholm - Stockholm Real Time Price. Currency in SEK
Follow
2.0800
-0.0050
(-0.24%)
As of 01:34PM CEST. Market open.
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
Expand All
All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
21,369
35,220
8,355
118,295
0
Cost of Revenue
119
-1,079
6
53,121
-
Gross Profit
21,250
36,299
8,349
65,174
0
Operating Expense
279,536
290,843
360,485
1,486,091
1,591,279
Operating Income
-258,286
-254,544
-352,136
-1,420,917
-1,591,279
Net Non Operating Interest Income Expense
-5,536
2,807
1,733
-456
-1,163
Pretax Income
-260,532
-248,447
-337,680
-1,421,372
-1,592,442
Tax Provision
2,170
664
271
8,946
2,251
Net Income Common Stockholders
-262,702
-249,111
-337,951
-1,430,317
-1,594,693
Diluted NI Available to Com Stockholders
-262,702
-249,111
-337,951
-1,430,317
-1,594,693
Basic EPS
-2.05
-1.97
-2.93
-13.54
-18.22
Diluted EPS
-2.05
-1.97
-2.93
-13.54
-18.22
Basic Average Shares
126,709
126,836
115,513
105,651
87,517
Diluted Average Shares
126,709
126,836
115,513
105,651
87,517
Total Operating Income as Reported
-257,189
-253,447
-349,350
-1,420,917
-1,591,279
Total Expenses
279,655
289,764
360,491
1,539,212
1,591,279
Net Income from Continuing & Discontinued Operation
-262,702
-249,111
-337,951
-1,430,317
-1,594,693
Normalized Income
-262,702
-249,111
-337,951
-1,430,317
-1,594,693
Interest Income
0
8,592
2,616
492
322
Interest Expense
528
5,785
883
948
1,485
Net Interest Income
-5,536
2,807
1,733
-456
-1,163
EBIT
-246,404
-242,662
-336,797
-1,420,424
-1,590,957
EBITDA
-246,404
-231,622
-319,636
-1,405,430
-1,576,554
Reconciled Cost of Revenue
119
-1,079
6
53,121
-
Reconciled Depreciation
4,540
11,040
17,161
14,994
14,403
Net Income from Continuing Operation Net Minority Interest
-262,702
-249,111
-337,951
-1,430,317
-1,594,693
Total Unusual Items Excluding Goodwill
0
0
0
0
-
Total Unusual Items
0
0
0
0
-
Normalized EBITDA
-246,404
-231,622
-319,636
-1,405,430
-1,576,554
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy controls
WA Consumer Health Privacy Policy
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.